Keywords: Selvita, Poland, Private placing, R&D pipeline, Cancer drugs, Auto-immune disorders

Poland’s Selvita raises $5.5 million to use in progressing R&D pipeline

Article | 09 May 2011

Print This

Selvita, the largest Polish drug discovery company, says it has entered into definitive agreements with investors in Poland to sell ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in